ARTICLE 1 DEFINITIONSLicense Agreement • March 16th, 2006 • Osi Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • Delaware
EXHIBIT 10.52 CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS. COLLABORATION AGREEMENTCollaboration Agreement • March 16th, 2006 • Osi Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
RECITALSLicensing Agreement • March 16th, 2006 • Osi Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • California
AGREEMENT BETWEENManufacturing and Supply Agreement • March 16th, 2006 • Osi Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
WHEREASLicense, Manufacturing and Supply Agreement • March 16th, 2006 • Osi Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • California
December 13, 2005 OSI Pharmaceuticals, Inc. 58 South Service Road Suite 110 Melville, NY 11747 Attention Michael G. Atieh, Executive Vice President & Chief Financial Officer Stephen R. Grillo, Director, Purchasing & Treasury Re: Commitment Letter...Osi Pharmaceuticals Inc • March 16th, 2006 • In vitro & in vivo diagnostic substances
500 Seventh Avenue 18(th) Floor New York, New York 10018 August 29, 2003 Raylo Chemicals Inc. 8045 Argyll Road Edmonton, Alberta Canada Attn: Matt Colomb Greg Klak Robin Nicol Gentlemen: This Letter of Understanding ("LOU") is agreed to and accepted...Osi Pharmaceuticals Inc • March 16th, 2006 • In vitro & in vivo diagnostic substances
